Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
24
AECLY Quote, Financials, Valuation and Earnings
Last price:
$5.00
Seasonality move
:
0%
Day range:
$5.00 - $5.00
52-week range:
$5.00 - $7.90
Dividend yield:
3.44%
P/E ratio:
20.38x
P/S ratio:
0.30x
P/B ratio:
1.27x
Volume:
--
Avg. volume:
--
1-year change:
-36.71%
Market cap:
$527.6M
Revenue:
$1.8B
EPS (TTM):
-$0.12
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.8B | $2.2B | $1.9B | $1.8B | |
| Revenue Growth (YoY) | -14.68% | 20.29% | 23.36% | -12.91% | -3.16% | |
| Cost of Revenues | $981M | $1.2B | $1.6B | $1.3B | $1.2B | |
| Gross Profit | $483.5M | $551.4M | $601.3M | $577.6M | $587.5M | |
| Gross Profit Margin | 33.01% | 31.3% | 27.67% | 30.52% | 32.06% | |
| R&D Expenses | $3.9M | $4.8M | $4.9M | $4.3M | $5M | |
| Selling, General & Admin | $427.8M | $412.6M | $476.3M | $473.7M | $503.3M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $371.6M | $412.6M | $448.4M | $441.7M | $484.5M | |
| Operating Income | $111.9M | $138.7M | $152.9M | $135.9M | $103M | |
| Net Interest Expenses | $22M | $17.4M | $24.5M | $33.8M | $35.2M | |
| EBT. Incl. Unusual Items | $38.6M | $124.7M | $105.8M | $105.1M | $55.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $4M | -$30.5M | |
| Income Tax Expense | $30.6M | $43.4M | $49M | $47.2M | $40.7M | |
| Net Income to Company | $55.7M | $138.7M | $125M | $139.2M | $55.7M | |
| Minority Interest in Earnings | $1.4M | $1.4M | $1.6M | $108.3K | $1.3M | |
| Net Income to Common Excl Extra Items | $9.7M | $81.8M | $58.4M | $60M | $16.6M | |
| Basic EPS (Cont. Ops) | $0.08 | $0.76 | $0.54 | $0.60 | -$0.15 | |
| Diluted EPS (Cont. Ops) | $0.07 | $0.75 | $0.53 | $0.59 | -$0.15 | |
| Weighted Average Basic Share | $105.5M | $105.5M | $105.5M | $105.5M | $105.5M | |
| Weighted Average Diluted Share | $110M | $106.8M | $106.1M | $107.5M | $105.5M | |
| EBITDA | $179.4M | $208.5M | $215.3M | $188.3M | $161.8M | |
| EBIT | $111.9M | $138.7M | $152.9M | $135.9M | $103M | |
| Revenue (Reported) | $1.5B | $1.8B | $2.2B | $1.9B | $1.8B | |
| Operating Income (Reported) | $111.9M | $138.7M | $152.9M | $135.9M | $103M | |
| Operating Income (Adjusted) | $111.9M | $138.7M | $152.9M | $135.9M | $103M | |
| Period Ending | 2022-02-15 | 2023-02-15 | 2024-02-15 | 2025-02-15 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $2B | $2.2B | $1.9B | $1.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.5B | $1.8B | $2B | $1.8B | $1.6B | |
| Gross Profit | $144.1M | $141.2M | $126.8M | $110.6M | $116.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | $144.1M | $141.2M | $126.8M | $110.6M | $116.6M | |
| Net Interest Expenses | $19.2M | $18.5M | $32.3M | $35M | $29.5M | |
| EBT. Incl. Unusual Items | $74.2M | $127M | $100.8M | $81.4M | $55.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $2.9M | -$32M | |
| Income Tax Expense | $42.1M | $44.7M | $48.5M | $44.2M | $37.6M | |
| Net Income to Company | $97.2M | $141.2M | $128.7M | $106.4M | $67.6M | |
| Minority Interest in Earnings | $2.5M | $1.6M | $1.2M | -$1.2M | $697.2K | |
| Net Income to Common Excl Extra Items | $33.5M | $82.7M | $54.7M | $38.2M | $20.3M | |
| Basic EPS (Cont. Ops) | $0.29 | $0.79 | $0.52 | $0.40 | -$0.12 | |
| Diluted EPS (Cont. Ops) | $0.27 | $0.78 | $0.50 | $0.39 | -$0.12 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $213.4M | $208.1M | $187.2M | $165.1M | $175.1M | |
| EBIT | $144.1M | $141.2M | $126.8M | $110.6M | $116.6M | |
| Revenue (Reported) | $1.6B | $2B | $2.2B | $1.9B | $1.7B | |
| Operating Income (Reported) | $144.1M | $141.2M | $126.8M | $110.6M | $116.6M | |
| Operating Income (Adjusted) | $144.1M | $141.2M | $126.8M | $110.6M | $116.6M | |
| Period Ending | 2023-02-15 | 2024-02-15 | 2025-02-15 | 2026-02-15 | 2027-02-15 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $269.3M | $146.2M | $148.8M | $138.7M | $156.7M | |
| Short Term Investments | $24.4M | $20.5M | $17.6M | $22M | $28.2M | |
| Accounts Receivable, Net | $288.9M | $305.5M | $390.9M | $338.8M | $330.2M | |
| Inventory | $256M | $305.8M | $398.5M | $335M | $271.2M | |
| Prepaid Expenses | $11.9M | $15.7M | $18M | $18.2M | $22.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $879.7M | $827.1M | $1B | $884.8M | $851.5M | |
| Property Plant And Equipment | $413.6M | $391.5M | $389.5M | $407.6M | $350.5M | |
| Long-Term Investments | $35.8M | $45.1M | $41.9M | $30.2M | $32.2M | |
| Goodwill | $161.3M | $148.4M | $138M | $126.1M | $85.5M | |
| Other Intangibles | $68.2M | $58.2M | $50.9M | $45.6M | $19.2M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.6B | $1.5B | $1.7B | $1.5B | $1.4B | |
| Accounts Payable | $273.3M | $296.9M | $354.8M | $323.4M | $285.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $10.2M | $7.3M | $7.7M | $7.3M | $8.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $530.3M | $493.5M | $843.6M | $494.7M | $465.1M | |
| Long-Term Debt | $258.8M | $209.8M | $67M | $293.8M | $269.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $873.2M | $788.8M | $975.8M | $849.3M | $804M | |
| Common Stock | $7.5M | $6.9M | $6.2M | $5.8M | $5.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $724.4M | $715.4M | $683.8M | $669.5M | $630.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $11.4M | $10.4M | $10.6M | $8.8M | $8.6M | |
| Total Equity | $736.3M | $726.1M | $694.8M | $678.7M | $639.6M | |
| Total Liabilities and Equity | $1.6B | $1.5B | $1.7B | $1.5B | $1.4B | |
| Cash and Short Terms | $269.3M | $146.2M | $148.8M | $138.7M | $156.7M | |
| Total Debt | $269M | $217.1M | $74.7M | $301.2M | $278M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $133M | $106.9M | $122.6M | $113.9M | $127.2M | |
| Short Term Investments | $23.6M | $20.5M | $24.4M | $30.4M | $35.1M | |
| Accounts Receivable, Net | $324.2M | $395.7M | $365.4M | $367.2M | $342.1M | |
| Inventory | $291.5M | $401.4M | $366.3M | $312.5M | $275M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $777.9M | $930.7M | $883M | $830.7M | $843.3M | |
| Property Plant And Equipment | $414.7M | $400.1M | $377.2M | $392.2M | $343.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $162.5M | $143.3M | $128.3M | $122.3M | $89M | |
| Other Intangibles | $65.5M | $54.1M | $47.1M | $41.8M | $18.6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.5B | $1.6B | $1.5B | $1.4B | $1.4B | |
| Accounts Payable | $326M | $390.7M | $346.9M | $334.7M | $309.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $6.3M | $5.7M | $6.1M | $5.5M | $4.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $417.6M | $605.3M | $715.8M | $442.2M | $385.5M | |
| Long-Term Debt | $241.5M | $191.9M | $42.1M | $250.1M | $225.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $764.6M | $910.4M | $849.9M | $779.2M | $693.6M | |
| Common Stock | $8.1M | $700.7M | $6M | $5.9M | $6.3M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $11.7M | $9.9M | $10.5M | $7.5M | $6.9M | |
| Total Equity | $743.4M | $710.5M | $656.3M | $660.8M | $661.1M | |
| Total Liabilities and Equity | $1.5B | $1.6B | $1.5B | $1.4B | $1.4B | |
| Cash and Short Terms | $156.6M | $127.4M | $147M | $144.2M | $162.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $55.7M | $138.7M | $125M | $139.2M | $55.7M | |
| Depreciation & Amoritzation | $67.5M | $69.8M | $62.4M | $52.4M | $58.9M | |
| Stock-Based Compensation | $2.4M | $3.6M | $3.8M | $2.8M | $2.1M | |
| Change in Accounts Receivable | -$16.2M | -$52.6M | -$124.9M | $18.9M | -$30.7M | |
| Change in Inventories | $14.5M | -$77.8M | -$126.1M | $33.1M | $42.2M | |
| Cash From Operations | $190.2M | $99.2M | $4.7M | $194.7M | $102.7M | |
| Capital Expenditures | $38.3M | $52.3M | $94.3M | $70.6M | $53.1M | |
| Cash Acquisitions | $5.3M | -- | -- | $3M | -- | |
| Cash From Investing | -$32.8M | -$45.4M | -$100M | -$77.9M | -$56.5M | |
| Dividends Paid (Ex Special Dividend) | $36.7M | $50.1M | $46.4M | $39.7M | $8.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $30.2M | $201.1M | $231M | $34.1M | |
| Long-Term Debt Repaid | -$13.1M | -$127M | -$46.7M | -$303.9M | -$32.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$366.6K | -- | -- | -- | -- | |
| Cash From Financing | -$72.2M | -$165.4M | $92.6M | -$123.7M | -$20.3M | |
| Beginning Cash (CF) | $242.2M | $122.4M | $121M | $107.2M | $126.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $88.4M | -$104.3M | $2.6M | -$1.7M | $28.1M | |
| Ending Cash (CF) | $333.8M | $25.3M | $128.8M | $110.7M | $156.9M | |
| Levered Free Cash Flow | $151.9M | $46.9M | -$89.6M | $124.1M | $49.6M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $97.2M | $141.2M | $128.7M | $106.4M | $67.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $169.4M | $7.4M | $118.2M | $130.6M | $134.5M | |
| Capital Expenditures | $45M | $74.6M | $76.6M | $63.4M | $40.9M | |
| Cash Acquisitions | $490.5K | -- | -- | $3M | -- | |
| Cash From Investing | -$37.5M | -$77.7M | -$72.2M | -$73.2M | $10.7M | |
| Dividends Paid (Ex Special Dividend) | $72.4M | $48.6M | $42.9M | $12.2M | $14.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $7.8M | $166.3M | $74.8M | $278.7M | -$32.7M | |
| Long-Term Debt Repaid | -$91.2M | -$50.3M | -$43.8M | -$302.8M | -$77M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$182.2M | $55.6M | -$35.7M | -$50.3M | -$135M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$64.1M | -$3.1M | $22.4M | $2.7M | $7.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $124.4M | -$67.2M | $41.5M | $67.2M | $93.6M | |
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Related Companies
Get AECLY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AECLY
Sector
P/E ratio
20.38x
--
PEG ratio
0.22x
--
P/B ratio
1.27x
--
Price / LTM sales
0.30x
--
Growth Metrics
AECLY
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
1.32%
--
Earnings forecast
--
--
Profitability
AECLY
Sector
Profitability FY 2024
$587.5M
--
Return on invested capital
-1.29%
--
Return on assets
-0.87%
--
Return on equity
-1.88%
--
Earnings Date
Last Earnings Date
Feb
15
Next Earnings Date
Feb
25
Estimated Next Earnings Date
May
17
Balance Sheet
AECLY
Sector
Total cash
$162.2M
--
Short term investments
$28.2M
--
Total assets
$1.4B
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
